We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

Basal Cell Carcinoma Treatment Reduces Tumor Size, Improves Surgical Removal

By HospiMedica International staff writers
Posted on 29 Jan 2025

Basal cell carcinomas, the most prevalent type of skin cancer, often appear in areas exposed to the sun, such as the face. More...

Locally advanced tumors, in particular, present challenges for surgical treatment. Now, a study published in Nature Cancer explored the effectiveness of a new therapy, yielding promising results. The treatment involved an active substance that led to tumor shrinkage in all participants, enhancing the effectiveness of surgical removal and, in some cases, resulting in complete tumor regression.

In the study, researchers from Medical University of Vienna (Vienna, Austria) used Talimogene Laherparepvec (TVEC), a treatment previously approved only for superficial melanoma metastases. TVEC is a genetically engineered herpes simplex virus designed to selectively destroy tumor cells while stimulating the immune system. The study aimed to reduce the tumor size prior to surgery, ensuring that patients would experience minimal functional or cosmetic limitations after the procedure. Eighteen patients with basal cell carcinoma, which would otherwise require a flap or skin graft due to its size and location, were given six intralesional injections of TVEC over 13 weeks before surgery.

The results were significant: half of the patients saw their tumors shrink sufficiently to allow for surgery with direct wound closure. In one-third of the cases, histological analysis post-surgery revealed no living tumor cells. All tumors treated with TVEC shrank, and none worsened during the therapy. The treatment was well tolerated by all patients. Additionally, the study included comprehensive analyses, demonstrating that TVEC therapy enhanced immune activity within the tumor tissue. These findings suggest that TVEC could serve as a promising neoadjuvant treatment for basal cell carcinoma, especially for patients who would benefit from avoiding major surgery. Further studies are planned to confirm the effectiveness of this approach in a broader patient group.

"The new treatment option for basal cell carcinoma can not only simplify surgery, but also help to avoid disfiguring operations and functional limitations," said first author Julia Ressler.


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Hybrid Arch Device
Neo EDE
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image Credit: Shutterstock

Explainable AI Examines Sepsis Mortality Risk and Emergency Care Delays

Preventing sepsis-related deaths in emergency departments (EDs) remains challenging because patient deterioration can result from multiple rapidly evolving and interconnected factors. These include triage... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image: A new automated approach could help predict which patients with dystonia will benefit from deep brain stimulation before surgery (Image Credit: Adobe Stock)

AI Uses Routine MRI to Predict Deep Brain Stimulation Response in Dystonia

Dystonia is a debilitating neurological movement disorder characterized by involuntary muscle contractions that cause abnormal movements and postures. Deep brain stimulation (DBS) is one of the few treatments... Read more

Health IT

view channel
Image Credit: Shutterstock

Telemonitoring Program Improves Quality of Life After Heart Failure Discharge

Heart failure is a chronic condition associated with high mortality, frequent hospitalizations, and reduced quality of life. Patients face particularly high risks of readmission and death after discharge,... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.